REG - FIL Limited Medtronic, Inc. Covidien plc - Form 8.3 - [Medtronic Inc] <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 7496VFIL Limited30 October 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
29-October-2014
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
32,742,688 3.36
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
3,900 0.00
Total
32,742,688 3.36
3,900 0.00
The above holding includes a transition into our holdings of 60 Shares.
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(63) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
5,000
67.305 USD/ Share
Buy
72,087
67.2425 USD/ Share
Buy
35,350
67.0733 USD/ Share
Buy
123,374
67.1246 USD/ Share
Buy
2,300
66.4035 USD/ Share
Buy
13,600
66.3808 USD/ Share
Buy
1,000
66.33 USD/ Share
Buy
8,782
66.346 USD/ Share
Buy
200
66.35 USD/ Share
Buy
187,318
66.47 USD/ Share
Buy
80,548
66.9648 USD/ Share
Buy
3,500
67.0991 USD/ Share
Buy
2,739
67.1107 USD/ Share
Buy
1,000
67.188 USD/ Share
Buy
2,500
67.25 USD/ Share
Buy
2,900
67.0178 USD/ Share
Buy
190,902
66.9047 USD/ Share
Sale
30
67.12 USD/ Share
Buy
20
67.17 USD/ Share
Sale
4,200
66.847 USD/ Share
Buy
2,000
67.0692 USD/ Share
Buy
7
66.33 USD/ Share
Sale
2
66.32 USD/ Share
Sale
32
66.39 USD/ Share
Buy
16
66.41 USD/ Share
Buy
12
66.38 USD/ Share
Buy
90
66.42 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
Call Option
Writing
400
USD 70.00
American
20 Dec 2014
0.70 USD/ Share
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,400
USD 70.00
American
20 December 2014
Date of disclosure
30 October 2014
Contact name
Sally-Ann Hatton
Telephone number
+44 (0)1737 837148
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDNARDMMFGDGZGDZM
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement